Eric Lefkofksy and Tmpus Use Machine Learning to Improve Cancer Treatment

Release Fact posted the article “Eric Lefkofsky’s Tempus Labs Uses Big Data Analytics to Revolutionize Cancer Medicine”. In the article, Blair Harris describes the top biotech start-up and its recent improvements in technology.

The company began in 2015 and has quickly risen to the top of the industry with its combination of gene editing technology and machine learning. Tempus labs became known as a leading provider of gene sequencing to provide specialized cancer treatment regimens. It works in collaboration with the National Cancer Institute to organize a library of data paired with genomic sequencing to provide more actionable insights for individualized treatment plans.

However, it has also had several biotechnologies approved by the FDA recently. One pairs gene editing and gene therapy to treat a form of inherited blindness like Hunter syndrome. By focusing on specific gene mutations, the company can create a vivo manipulation.

Tempus is also quickly advancing technology in identifying skin cancers. Their machine learning algorithms have become almost as capable as physicians, equaling their abilities to find and diagnose both malignant and benign melanoma.

They also approved FDA approval for a watch that monitors blood pressure. It simply reads blood pressure by interpreting information from the radial artery. Tempus also has AI technology for diagnosing eye issues in a cheaper way than clinicians. The algorithms identify diabetic retinopathy and other eye complications.

Tempus was co-founded in 2015 by Eric Lefkofsky. The company quickly became evaluated at $700 million because of its innovations of a comprehensive analytical machine learning platform with which doctors and physicians can interact. The purpose of the company is to use information from those who have experienced cancer before and apply it to current patients. It helps physicians create real-time precision medicine treatment plans for each individual while using metadata to discover the best methodology.

Eric Lefkofsky created the company after having a close experience with the pain of cancer treatment when a close acquaintance went through the process. Lefkofsky is known for his work as a serial entrepreneur, starting many companies in transportation, advertising technology, venture capital, and analytics. Lefkofksy is also a devoted philanthropist.

To know more click: here.